with a fixed, dilated pupil and a positive reverse relative afferent pupillary defect. The patient exhibited marked proptosis and chemosis (Fig. 1A) . The intraocular pressure was 25 mm Hg. The fundal view was limited due to dense corneal punctate epithelial erosions and corneal abrasion. Extraocular movements were limited in all directions. Findings from the left-eye ophthalmic examination were normal.
The orbit was isointense on T1-weighted MRI, and the lesion appeared mixed hypo-/hyperintense on T2-weighted MRI, with internal hemorrhage seen in the gradient echo sequence involving both intraconal and extraconal spaces of the right orbit that extended posteriorly into the superior orbital fissure. There was a peripheral thin rim and septal enhancement ( Fig. 2A ). An LVM with acute intralesional bleeding was suspected. The patient underwent diagnostic angiography after induction of general anesthesia, which revealed a contrast-filled lesion in the right orbit that was fed from the orbital branch of the right ophthalmic artery and drained into the right SOV and right cavernous sinus, consistent with an AVF (Fig.  3) . Direct puncture using a 20-gauge catheter (Jelco) under fluoroscopic guidance was performed in the medial 2 cysts of the LVM in preparation for bleomycin injection. Then, Hexabrix (320 mg/ml) contrast was injected to localize the position of the Jelco tip and demonstrated contrast drainage to the right SOV and right cavernous sinus. The diagnosis of an orbital LVM with an intraorbital AVF was made. Thus, the catheter was withdrawn, and the strategy was changed. Treatment was initiated via a transvenous approach to obliterate the fistula first before direct puncture with bleomycin injection. A 2.3-Fr Prowler Plus microcatheter (Codman Neuro) was navigated into the right SOV, and microcoil embolization was done using 1 Tornado embolization coil (3 mm × 2 cm, Cook Medical) and 14 Nester embolization coils (3 mm × 14 cm, Cook Medical). Postembolization angiography demonstrated 90% flow reduction in the intraorbital AVF.
Direct puncture with contrast injection under fluoroscopic guidance was done again into the same medial cyst, which still revealed slow-flow venous drainage to the right SOV and right cavernous sinus. Furthermore, the cavity was freely aspirated, which resulted in obtaining 50 ml of blood, indicating a residual fistula and incomplete outflow occlusion. Therefore, plans for sclerosing therapy of the LVM were abandoned.
Clinical improvement from thrombotic effects at the interventional site was expected. However, 1 week later, the patient had no clinical improvement. He underwent cerebral angiography, which showed minimal residual slow flow in the AVF with venous drainage into the right SOV and right cavernous sinus. After a multidisciplinary meeting, we decided to proceed with surgical removal of the LVM after glue embolization instead of intralesional bleomycin injection due to the inability to close the AVF completely. Transfemoral transvenous glue embolization via the right SOV was combined with percutaneous intralesional glue injection at the superomedial and inferomedial areas of the LVM using 33% mixtures of N-butyl cyanoacrylate with lipiodol. Volumes of 1.5 ml (in the AVF), 2.5 ml (in the superomedial portion of the LVM), and 2.0 ml (in the inferomedial portion of the LVM) were injected in an attempt to close the systemic connection and enable excision. Excision of the superomedial and inferomedial components was performed 5 days later via a lateral orbitotomy. Histopathological examination revealed multiple dilated sacs lined with a single layer of endothelium of the LVM with organized thrombus and glue. At the 1-week follow-up, the patient's vision was unchanged, but his proptosis and chemosis were dramatically diminished.
At the 3-month follow-up, the patient exhibited 3 mm of proptosis with minimal supraduction and abduction deficit. There was a significant decrease in the size of the LVM on repeated MRI of the orbit (Figs. 1B and 2B ). The patient has been stable with no recurrence of the LVM or intraorbital AVF during a 2-year follow-up period.
Discussion
Orbital LVMs are rare, benign, congenital vascular malformations. These lesions may be seen at birth but are generally not clinically apparent until infancy or childhood. They may present after an upper respiratory tract infection, trauma, or with acute intralesional bleeding. The most common presentations are proptosis, ptosis, swelling of periorbital soft tissue, and restriction of eye movement. There are various systems of classification of orbital LVMs. These lesions are categorized as no-flow to slowflow lesions based on the Orbital Society recommendations. 5 According to the International Society for the Study of Vascular Anomalies classification, they are classified as slow-flow malformations. 13 In terms of location, orbital LVMs are further grouped as superficial, deep, combined, and complex. 11 Rootman et al. 9 considered the hemodynamic effect of size and type of inflow and outflow channels important. Therefore, orbital lesions have been categorized as pure lymphatic malformations and combined LVMs. LVMs are relatively more common than pure lymphatic malformations and have a variable venous component with a variable range of connection to the systemic venous circulation. Combined lymphatic-dominant lymphatic malformations and pure lymphatic malformations demonstrate little or no evidence of systemic venous outflow, while combined venous-dominant LVMs can have a large venous outflow to the systemic circulation. Histologically, orbital LVMs have multiple dilated sacs and lobules lined with a single layer of endothelium, containing a proteinaceous or serosanguinous fluid with connective tissue stroma, smooth muscle bundles, dense small lymphocytes or follicles, and stromal hemorrhage. 8 Regarding the correlation between orbital LVMs and other vascular malformations, there is a significant association between diffuse orbital LVMs and noncontiguous intracranial vascular anomalies, including developmental venous anomalies, dural arteriovenous malformations, occlusion or absence of dural sinuses and jugular veins, cerebral cavernous malformations, and pial arteriovenous malformations. 1 Coll et al. reported a case of concomitant medial extraconal orbital lymphangioma and ipsilateral arteriovenous malformation of the orbit and middle cranial fossa. 2 Coumou et al. reported a case of a carotid-cavernous dural AVF concomitant with a venous/lymphatic malformation. 3 To the best of our knowledge, we describe the first case of an orbital LVM with concomitant spontaneous orbital AVF.
Intraorbital AVFs are a challenge to diagnose and manage. The clinical manifestations, including eye redness, proptosis, visual loss, diplopia, orbital pain, and bruits, may mimic those of carotid-cavernous sinus fistulas. 7 The etiology of a traumatic intraorbital AVF is a penetrating injury causing perforation of both the artery and vein where they cross each other, whereas the mechanism of a spontaneous orbital AVF is not clear. Theories include a preexisting ophthalmic artery aneurysm that ruptures into an adjacent vein or gradual mechanical erosion of an artery from hypertension, atherosclerosis, or other vascular diseases. 15 In our case, we postulate that the mechanism of this spontaneous intraorbital AVF could be from the local mechanical erosion of the ophthalmic artery caused by the multiple lobulated masses of the orbital LVM.
The management of both orbital LVMs and orbital AVFs is challenging. Orbital LVMs are irregular, infiltrative lesions involving adjacent vital structures of the orbit. They are rich with vascular beds, which can lead to uncontrolled bleeding and may also have no accessible vascular channels for endovascular approaches. 12 Conservative treatment is recommended for lesions that cause no visual deficits or cosmetic issues. The nonsurgical strategies previously reported for orbital LVMs are sclerosing therapy including ethanol, OK-432, sodium tetradecyl sulfate (Sotradecol, Mylan), morrhuate sodium, doxycycline, bleomycin, and pinyangmycin. 8, 11, 12 A carbon dioxide laser, beta irradiation, and adjunctive systemic corticosteroids are also options for treatment. 8 Recently, the use of oral sildenafil for the treatment of microcystic lesions has been reported. 8 Surgical management can be combined with preoperative intralesional injection of sclerosing agents (e.g., morrhuate sodium) or liquid polymers (e.g., N-butyl cyanoacrylate glue or fibrin glue) to aid in dissection and improve hemostasis. 8, 11 In the case of an orbital AVF, small low-flow lesions may have spontaneous remission or resolution after diagnostic angiography. 15 Conservative treatment is favored in those with no significant symptoms. In cases with progressive orbital congestive symptoms and visual deficit, treatment with endovascular embolization (via transvenous, transarterial, or direct surgical approaches) 7 is an option. Alternative treatment strategies include embolization followed by resection 10 or surgery alone. 4, 14 The standard treatment is not well established due to the rarity of these lesions, but transvenous embolization with coils, oxidized cellulose (Surgicel, Ethicon), or Onyx 7 has been most frequently reported with satisfactory outcomes. In our patient, the angiogram demonstrated both the orbital LVM with venous outflow drainage to systemic circulation and an orbital AVF; therefore, a combination of treatments was used. We performed a transfemoral transvenous approach via the right SOV for coil embolization of the fistula and venous outflow drainage of the LVM to close the systemic connection and inject the bleomycin. However, the fistula remained partially patent, and the outflow occlusion was incomplete. Hence, further transfemoral transvenous embolization with cyanoacrylate glue instead of bleomycin was used to close the residual fistula and venous outflow, posteriorly combined with percutaneous intralesional glue injection into the LVM anteriorly. Resection of the LVM was performed in the same admission to avoid a foreign body reaction caused by cyanoacrylate glue.
Conclusions
An intraorbital AVF can be found to coexist with lowflow orbital LVMs. Diagnostic carotid angiography should be considered in cases of orbital LVMs to exclude abnormal high-flow shunting. In our case, preoperative CT scanning and MRI did not reveal this high-flow abnormality. Management by a multidisciplinary team involving oculoplastic surgeons and interventional neuroradiologists is essential for the optimal management of these lesions.
